Does ROMIPLOSTIM Cause Malignant neoplasm progression? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Malignant neoplasm progression have been filed in association with ROMIPLOSTIM (Nplate). This represents 0.1% of all adverse event reports for ROMIPLOSTIM.
7
Reports of Malignant neoplasm progression with ROMIPLOSTIM
0.1%
of all ROMIPLOSTIM reports
4
Deaths
5
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ROMIPLOSTIM?
Of the 7 reports, 4 (57.1%) resulted in death, 5 (71.4%) required hospitalization, and 2 (28.6%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROMIPLOSTIM. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does ROMIPLOSTIM Cause?
Off label use (1,027)
Platelet count decreased (892)
Platelet count abnormal (703)
Drug ineffective (513)
Thrombocytopenia (369)
Headache (359)
Death (356)
Product storage error (344)
Fatigue (251)
Circumstance or information capable of leading to medication error (238)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ROMIPLOSTIM Alternatives Have Lower Malignant neoplasm progression Risk?
ROMIPLOSTIM vs ROMOSOZUMAB
ROMIPLOSTIM vs ROMOSOZUMAB-AQQG
ROMIPLOSTIM vs ROPEGINTERFERON ALFA-2B-NJFT
ROMIPLOSTIM vs ROPINIROLE
ROMIPLOSTIM vs ROPIVACAINE